Bio-Rad Labs Inc. A buy UBS Group AG
Start price
16.02.24
/
50%
€316.20
Target price
16.02.25
€389.51
Performance (%)
-15.75%
End price
17.02.25
€266.40
Summary
This prediction ended on 17.02.25 with a price of €266.40. The price of Bio-Rad Labs Inc. A has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -15.75%. UBS_Group_AG has a follow-up prediction for Bio-Rad Labs Inc. A where he still thinks Bio-Rad Labs Inc. A is a Buy. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bio-Rad Labs Inc. A | 9.528% | 9.528% | -22.320% |
| iShares Core DAX® | -0.695% | 0.275% | 33.736% |
| iShares Nasdaq 100 | -0.520% | 3.779% | 19.025% |
| iShares Nikkei 225® | 0.870% | 1.365% | 9.546% |
| iShares S&P 500 | -0.737% | 3.346% | 12.882% |
Comments by UBS_Group_AG for this prediction
In the thread Bio-Rad Labs Inc. A diskutieren
Bio-Rad Laboratories, Inc. (NYSE: BIO) had its price target raised by analysts at UBS Group AG from $395.00 to $420.00. They now have a "buy" rating on the stock.
Ratings data for BIO provided by MarketBeat
In the thread Trading Bio-Rad Labs Inc. A
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten
Current prediction by UBS_Group_AG for Bio-Rad Labs Inc. A
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€205.90
03.05.25
03.05.25
€274.38
03.05.26
03.05.26
18.89%
04.08.25
04.08.25
Stopped prediction by UBS_Group_AG for Bio-Rad Labs Inc. A
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€248.20
08.05.24
08.05.24
€357.93
08.05.25
08.05.25
-12.97%
09.05.25
09.05.25
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€285.60
07.12.23
07.12.23
€365.97
07.12.24
07.12.24
8.65%
08.12.24
08.12.24